Original research
Adverse drug reaction risk factors in older outpatients

https://doi.org/10.1016/S1543-5946(03)90004-3Get rights and content

Abstract

Background: Adverse drug reactions (ADRs) are common in older (age ≥65 years) outpatients (prevalence, 5%–35%), but there is no consensus on factors that put these patients at high risk for ADRs. Identifying a uniform set of risk factors would be helpful to develop risk models for ADRs for older outpatients and to implement targeted interventions for those patients at high risk for ADRs.

Objective: The aim of this study was to identify potential risk factors for ADRs in older outpatients through a survey of geriatric experts and to determine their prevalence.

Methods: A comprehensive literature search was conducted to find published articles on ADRs in older patients. Forty-four potential risk factors were identified through the literature search and 6 additional factors were suggested by the expert panel. Through a modified 2-round survey, based on the Delphi consensus method, of an expert panel of 5 physicians and 5 pharmacists, the probability that each of these 50 potential factors could contribute independently to placing an older outpatient at high risk for an ADR was rated on a 5-point Likert scale. After the survey responses were received, means and 95% Cls were calculated. Consensus was defined as a lower 95% confidence limit ≥4.0. Potential risk factors that reached consensus were then applied to a sample of older outpatients to determine their prevalence.

Results: After 2 rounds, the expert panel reached consensus on 21 factors, including 12 medication-related factors and 9 patient characteristics. The most prevalent medication-related risk factors were opioid analgesics; warfarin; non-acetylsalicylic acid, non-cyclooxygenase-2 nonsteroidal anti-inflammatory drugs; anticholinergics; and benzodiazepines. The most prevalent patient characteristics included polypharmacy, multiple chronic medical problems, prior ADR, and dementia.

Conclusions: An expert panel was able to reach a consensus on potential risk factors that increase the risk for ADRs in older outpatients. Many risk factors were common in a sample of older outpatients. Future research is needed to determine the predictive validity of these risk factors for ADRs in older outpatients.

References (37)

  • E.A. Chrischilles et al.

    Self-reported adverse drug reactions and related resource use. A study of community-dwelling persons 65 years of age and older

    Ann Intern Med.

    (1992)
  • Committee on Quality of Health Care in America et al.

    To Err Is Human: Building a Safer Health System

  • M.M. Fouts et al.

    Identification of elderly nursing facility residents at high risk for drugrelated problems

    Consult Pharm.

    (1997)
  • J.A. Koecheler et al.

    Indicators for the selection of ambulatory patients who warrant pharmacist monitoring

    Am J Hosp Pharm.

    (1989)
  • S.L. Gray et al.

    Adverse drug events in elderly patients receiving home health services following hospital discharge

    Ann Pharmacother.

    (1999)
  • R.E. Grymonpre et al.

    Drug-associated hospital admissions in older medical patients

    J Am Geriatr Soc.

    (1988)
  • S.L. Gray et al.

    Adverse drug events in hospitalized elderly

    J Gerontol A Biol Sci Med Sci.

    (1998)
  • C.K. Mannesse et al.

    Contribution of adverse drug reactions to hospital admission of older patients

    Age Ageing.

    (2000)
  • Cited by (145)

    • Design, implementation, and evaluation of educational workshop on management of Parkinson's and Alzheimer's disease patients for third-year pharmacy students

      2018, Currents in Pharmacy Teaching and Learning
      Citation Excerpt :

      Management of persons with PD and AD presents health care professionals with many challenges, such as dealing with the progressive nature of a chronic disease and complex medication regimens with increasing medical and therapeutic complications, as well as advanced age of individuals affected by these disorders.4–9 Clinically relevant drug-drug and drug-disease/condition interactions and adverse drug events are common problems in persons with PD and AD, and can significantly impact morbidity and mortality.10–17 These drug-related problems (DRPs) can usually be prevented with appropriate medication selection and administration, and proper patient medication education.5,10,12–14,18

    View all citing articles on Scopus
    View full text